

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.32348172 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.32348172 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.32348172 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.32348172 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.32348172 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.32348172 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03151209 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.42304346 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.24299667 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.17840680 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 4.17300585 |
| 12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.15937738 |
| 13 | detection of other organism (GO:0098543) | 4.13001475 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.06694889 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.00284872 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.93704667 |
| 17 | response to peptidoglycan (GO:0032494) | 3.92777563 |
| 18 | detection of bacterium (GO:0016045) | 3.92407719 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 3.88839471 |
| 20 | respiratory burst (GO:0045730) | 3.86054085 |
| 21 | response to host immune response (GO:0052572) | 3.84438635 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.84438635 |
| 23 | neutrophil activation (GO:0042119) | 3.82572988 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.77576545 |
| 25 | microglial cell activation (GO:0001774) | 3.71301993 |
| 26 | detection of external biotic stimulus (GO:0098581) | 3.68688820 |
| 27 | granulocyte activation (GO:0036230) | 3.68504083 |
| 28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.63162679 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.61765833 |
| 30 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.61565578 |
| 31 | response to interferon-alpha (GO:0035455) | 3.61411408 |
| 32 | T cell migration (GO:0072678) | 3.59917065 |
| 33 | positive regulation of type 2 immune response (GO:0002830) | 3.57628471 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.57368447 |
| 35 | negative regulation of cell killing (GO:0031342) | 3.57368447 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.55687363 |
| 37 | cellular response to interferon-gamma (GO:0071346) | 3.51833302 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.46559545 |
| 39 | response to type I interferon (GO:0034340) | 3.39813832 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.39310181 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.39130008 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.39130008 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39070246 |
| 44 | response to host (GO:0075136) | 3.37708705 |
| 45 | response to host defenses (GO:0052200) | 3.37708705 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37708705 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.36974957 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 3.35261359 |
| 49 | superoxide anion generation (GO:0042554) | 3.34452831 |
| 50 | cellular extravasation (GO:0045123) | 3.33487553 |
| 51 | response to interleukin-15 (GO:0070672) | 3.33433548 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.32759179 |
| 53 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.32157469 |
| 54 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.32017611 |
| 55 | * response to interferon-beta (GO:0035456) | 3.31482688 |
| 56 | defense response to protozoan (GO:0042832) | 3.31406970 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28011074 |
| 58 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28011074 |
| 59 | response to muramyl dipeptide (GO:0032495) | 3.26757208 |
| 60 | leukocyte aggregation (GO:0070486) | 3.25907157 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.23487050 |
| 62 | response to interferon-gamma (GO:0034341) | 3.22999680 |
| 63 | detection of biotic stimulus (GO:0009595) | 3.21564810 |
| 64 | negative thymic T cell selection (GO:0045060) | 3.20921890 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.19228825 |
| 66 | positive thymic T cell selection (GO:0045059) | 3.17961644 |
| 67 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.17484609 |
| 68 | positive regulation of interferon-beta production (GO:0032728) | 3.17362114 |
| 69 | cellular response to zinc ion (GO:0071294) | 3.17270792 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 3.16327709 |
| 71 | B cell homeostasis (GO:0001782) | 3.14377720 |
| 72 | mature B cell differentiation (GO:0002335) | 3.13946840 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.13744660 |
| 74 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.13069579 |
| 75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.11721862 |
| 76 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10600806 |
| 77 | regulation of interleukin-12 production (GO:0032655) | 3.10357450 |
| 78 | negative T cell selection (GO:0043383) | 3.09575473 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08457663 |
| 80 | negative regulation of B cell proliferation (GO:0030889) | 3.07340888 |
| 81 | interferon-gamma secretion (GO:0072643) | 3.02974820 |
| 82 | defense response to virus (GO:0051607) | 3.01132244 |
| 83 | cellular response to exogenous dsRNA (GO:0071360) | 3.01014022 |
| 84 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99981278 |
| 85 | myeloid dendritic cell activation (GO:0001773) | 2.99129328 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.99012110 |
| 87 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.98491260 |
| 88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98163492 |
| 89 | germinal center formation (GO:0002467) | 2.96936805 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 2.96244070 |
| 91 | negative regulation of innate immune response (GO:0045824) | 2.94622711 |
| 92 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.93997660 |
| 93 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.93909183 |
| 94 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.93583146 |
| 95 | natural killer cell mediated immunity (GO:0002228) | 2.93583146 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92689357 |
| 97 | B cell mediated immunity (GO:0019724) | 2.92287278 |
| 98 | positive regulation of interleukin-12 production (GO:0032735) | 2.92163816 |
| 99 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91770941 |
| 100 | mast cell activation (GO:0045576) | 2.90969533 |
| 101 | regulation of activation of Janus kinase activity (GO:0010533) | 2.90191373 |
| 102 | neutrophil mediated immunity (GO:0002446) | 2.90040099 |
| 103 | response to protozoan (GO:0001562) | 2.89645601 |
| 104 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89586309 |
| 105 | regulation of antigen processing and presentation (GO:0002577) | 2.88394369 |
| 106 | NIK/NF-kappaB signaling (GO:0038061) | 2.86781383 |
| 107 | tolerance induction (GO:0002507) | 2.84877563 |
| 108 | positive regulation of mast cell activation (GO:0033005) | 2.84778213 |
| 109 | interferon-gamma production (GO:0032609) | 2.84564247 |
| 110 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83135154 |
| 111 | positive regulation of mast cell degranulation (GO:0043306) | 2.83135154 |
| 112 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83093257 |
| 113 | regulation of mast cell activation (GO:0033003) | 2.82907887 |
| 114 | positive regulation of interleukin-17 production (GO:0032740) | 2.82856191 |
| 115 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.82507744 |
| 116 | negative regulation of interleukin-17 production (GO:0032700) | 2.82083366 |
| 117 | negative regulation of interleukin-12 production (GO:0032695) | 2.81979258 |
| 118 | regulation of interleukin-17 production (GO:0032660) | 2.81288856 |
| 119 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.79096143 |
| 120 | macrophage activation (GO:0042116) | 2.78319267 |
| 121 | B cell proliferation (GO:0042100) | 2.77867216 |
| 122 | I-kappaB phosphorylation (GO:0007252) | 2.77394734 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.75447469 |
| 124 | * cellular response to interferon-beta (GO:0035458) | 2.74726484 |
| 125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.74599939 |
| 126 | dendritic cell migration (GO:0036336) | 2.73458395 |
| 127 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.73272945 |
| 128 | myeloid leukocyte activation (GO:0002274) | 2.73129291 |
| 129 | dendritic cell chemotaxis (GO:0002407) | 2.72934301 |
| 130 | * positive regulation of defense response to virus by host (GO:0002230) | 2.72201281 |
| 131 | negative regulation of viral genome replication (GO:0045071) | 2.71789746 |
| 132 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71659676 |
| 133 | positive regulation of isotype switching (GO:0045830) | 2.69989219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.42309727 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.12654719 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.79687726 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.00303869 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.83289286 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.18611443 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.11171857 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.93122531 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.77138861 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72403532 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.57183844 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.34215020 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.30251934 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15060473 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.82656158 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.62724110 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62044770 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51053358 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43225301 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.38130706 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.22108138 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.18537294 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.15190963 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03677627 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.03097131 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95310582 |
| 27 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88820613 |
| 28 | * MYB_26560356_Chip-Seq_TH1_Human | 1.87164931 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84262890 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76946435 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72309738 |
| 32 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.69558911 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68352629 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67012581 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66632323 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61167232 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.61153419 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57919901 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.56498098 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52827032 |
| 41 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50631406 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48259284 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46093095 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44011683 |
| 45 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36884130 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36091725 |
| 47 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32947462 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30920196 |
| 49 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30172767 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29392816 |
| 51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.26706933 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24870014 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22421842 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21674645 |
| 55 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21597777 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20492005 |
| 57 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.18438988 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18132724 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.17814916 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12382183 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09885748 |
| 62 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09448676 |
| 63 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.06528731 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06428781 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04736867 |
| 66 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04286404 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02380328 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.00493075 |
| 69 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.99932425 |
| 70 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99314700 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99070121 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98110165 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96937506 |
| 74 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96458420 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93038563 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92510370 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91594476 |
| 78 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90485750 |
| 79 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90298520 |
| 80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89997664 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.88524773 |
| 82 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88502966 |
| 83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87571972 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86624586 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83434987 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83390766 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 0.82650627 |
| 88 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80931357 |
| 89 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78206389 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77151852 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.76720132 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76287444 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.76047185 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76035824 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74242081 |
| 96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73562908 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72727310 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71836499 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71770808 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71663860 |
| 101 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71347616 |
| 102 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.70651049 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70015802 |
| 104 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69744217 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.69157545 |
| 106 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.67916276 |
| 107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67858177 |
| 108 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67133870 |
| 109 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.67075353 |
| 110 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.66226610 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65515359 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65052299 |
| 113 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.62887626 |
| 114 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.62625099 |
| 115 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.60923747 |
| 116 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.60350069 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.60193964 |
| 118 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 0.60045548 |
| 119 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59149225 |
| 120 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.57599700 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57586135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.53586467 |
| 2 | MP0009785_altered_susceptibility_to | 3.44900429 |
| 3 | MP0005671_abnormal_response_to | 3.43680669 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.32535035 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.29755113 |
| 6 | MP0001800_abnormal_humoral_immune | 3.20874401 |
| 7 | MP0001790_abnormal_immune_system | 3.17224128 |
| 8 | MP0005387_immune_system_phenotype | 3.17224128 |
| 9 | MP0003436_decreased_susceptibility_to | 3.12945954 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.96069811 |
| 11 | * MP0005025_abnormal_response_to | 2.91139678 |
| 12 | * MP0002419_abnormal_innate_immunity | 2.90325612 |
| 13 | * MP0002723_abnormal_immune_serum | 2.84496073 |
| 14 | MP0000685_abnormal_immune_system | 2.83806332 |
| 15 | MP0006082_CNS_inflammation | 2.73585552 |
| 16 | MP0003303_peritoneal_inflammation | 2.68920605 |
| 17 | * MP0001819_abnormal_immune_cell | 2.60700475 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.59604120 |
| 19 | MP0003724_increased_susceptibility_to | 2.45948328 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.42881560 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.22032943 |
| 22 | MP0005174_abnormal_tail_pigmentation | 2.19489345 |
| 23 | MP0008057_abnormal_DNA_replication | 2.16105290 |
| 24 | MP0002398_abnormal_bone_marrow | 2.12105192 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.09743920 |
| 26 | * MP0000716_abnormal_immune_system | 2.06572969 |
| 27 | MP0002405_respiratory_system_inflammati | 1.97038961 |
| 28 | MP0002006_tumorigenesis | 1.89707092 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.88460992 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.87881203 |
| 31 | MP0001853_heart_inflammation | 1.85532152 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.76692670 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.76134182 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.75622443 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.75427057 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.74452930 |
| 37 | MP0004510_myositis | 1.72079557 |
| 38 | MP0004947_skin_inflammation | 1.71683702 |
| 39 | MP0002277_abnormal_respiratory_mucosa | 1.70369914 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.68677676 |
| 41 | MP0005310_abnormal_salivary_gland | 1.67341769 |
| 42 | * MP0002429_abnormal_blood_cell | 1.66005559 |
| 43 | MP0002722_abnormal_immune_system | 1.64698812 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.63783772 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.62657500 |
| 46 | MP0003448_altered_tumor_morphology | 1.50049256 |
| 47 | MP0009278_abnormal_bone_marrow | 1.47026796 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.46870750 |
| 49 | MP0001873_stomach_inflammation | 1.42301307 |
| 50 | MP0000490_abnormal_crypts_of | 1.37748047 |
| 51 | MP0009764_decreased_sensitivity_to | 1.37017983 |
| 52 | * MP0008469_abnormal_protein_level | 1.33596918 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.32840159 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.31543287 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.31543287 |
| 56 | MP0000858_altered_metastatic_potential | 1.30361113 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.25565609 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.24918670 |
| 59 | MP0003866_abnormal_defecation | 1.24657067 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.15584919 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.13924979 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.13047150 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.10442884 |
| 64 | MP0010307_abnormal_tumor_latency | 1.08291222 |
| 65 | MP0001851_eye_inflammation | 1.05896823 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.03251630 |
| 67 | MP0008058_abnormal_DNA_repair | 1.01969080 |
| 68 | MP0002933_joint_inflammation | 0.99415480 |
| 69 | MP0008877_abnormal_DNA_methylation | 0.98968623 |
| 70 | MP0003828_pulmonary_edema | 0.96123033 |
| 71 | MP0004883_abnormal_blood_vessel | 0.93303349 |
| 72 | MP0000343_altered_response_to | 0.91853151 |
| 73 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89670787 |
| 74 | MP0003136_yellow_coat_color | 0.87461731 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.86580774 |
| 76 | MP0010094_abnormal_chromosome_stability | 0.84872623 |
| 77 | MP0004381_abnormal_hair_follicle | 0.83601882 |
| 78 | MP0002095_abnormal_skin_pigmentation | 0.83268293 |
| 79 | MP0000371_diluted_coat_color | 0.79697272 |
| 80 | MP0003075_altered_response_to | 0.79091892 |
| 81 | MP0009763_increased_sensitivity_to | 0.75557448 |
| 82 | MP0002653_abnormal_ependyma_morphology | 0.75466785 |
| 83 | MP0005451_abnormal_body_composition | 0.74414359 |
| 84 | MP0001663_abnormal_digestive_system | 0.74243375 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.72112605 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.70988379 |
| 87 | MP0005164_abnormal_response_to | 0.68919555 |
| 88 | MP0005390_skeleton_phenotype | 0.67563176 |
| 89 | MP0008260_abnormal_autophagy | 0.67343446 |
| 90 | MP0002009_preneoplasia | 0.67105532 |
| 91 | MP0002132_abnormal_respiratory_system | 0.65981571 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.65953296 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 0.65891907 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.65123153 |
| 95 | MP0005166_decreased_susceptibility_to | 0.64854942 |
| 96 | MP0003077_abnormal_cell_cycle | 0.62576043 |
| 97 | MP0008004_abnormal_stomach_pH | 0.62137907 |
| 98 | MP0008874_decreased_physiological_sensi | 0.60331319 |
| 99 | MP0000604_amyloidosis | 0.59325477 |
| 100 | MP0003690_abnormal_glial_cell | 0.58721245 |
| 101 | MP0002254_reproductive_system_inflammat | 0.58478624 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.57663269 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.57570199 |
| 104 | MP0000249_abnormal_blood_vessel | 0.57191074 |
| 105 | MP0005076_abnormal_cell_differentiation | 0.56876095 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.54976572 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.53697258 |
| 108 | MP0008873_increased_physiological_sensi | 0.52078530 |
| 109 | MP0002163_abnormal_gland_morphology | 0.49608935 |
| 110 | MP0002928_abnormal_bile_duct | 0.49253256 |
| 111 | MP0005266_abnormal_metabolism | 0.48837089 |
| 112 | MP0005409_darkened_coat_color | 0.48605669 |
| 113 | MP0000470_abnormal_stomach_morphology | 0.47958662 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.47870243 |
| 115 | MP0003787_abnormal_imprinting | 0.47040242 |
| 116 | MP0003091_abnormal_cell_migration | 0.46936606 |
| 117 | MP0003045_fibrosis | 0.46821211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.19584387 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.62031327 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.58087196 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 4.25298522 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.21764705 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.06868273 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 3.95519407 |
| 8 | Obstructive lung disease (HP:0006536) | 3.95519407 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.94073024 |
| 10 | Recurrent skin infections (HP:0001581) | 3.87144875 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 3.83967753 |
| 12 | Recurrent viral infections (HP:0004429) | 3.82281845 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.81419309 |
| 14 | Myositis (HP:0100614) | 3.78404851 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.68822508 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.68822508 |
| 17 | Vasculitis (HP:0002633) | 3.68091006 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.51200191 |
| 19 | Optic neuritis (HP:0100653) | 3.51200191 |
| 20 | Stomatitis (HP:0010280) | 3.49509771 |
| 21 | Meningitis (HP:0001287) | 3.38202238 |
| 22 | IgM deficiency (HP:0002850) | 3.33976708 |
| 23 | Gingivitis (HP:0000230) | 3.28784239 |
| 24 | Orchitis (HP:0100796) | 3.25326553 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.16007697 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.11976706 |
| 27 | Cellulitis (HP:0100658) | 3.11216186 |
| 28 | Prostate neoplasm (HP:0100787) | 3.07684216 |
| 29 | Chronic otitis media (HP:0000389) | 3.07340972 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05697778 |
| 31 | Agammaglobulinemia (HP:0004432) | 3.05189997 |
| 32 | Pustule (HP:0200039) | 3.04136742 |
| 33 | Recurrent pneumonia (HP:0006532) | 3.03821836 |
| 34 | Increased IgM level (HP:0003496) | 3.02137392 |
| 35 | Chest pain (HP:0100749) | 2.90235014 |
| 36 | Gangrene (HP:0100758) | 2.88561168 |
| 37 | Periodontitis (HP:0000704) | 2.86149509 |
| 38 | Thyroiditis (HP:0100646) | 2.85917106 |
| 39 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.84824797 |
| 40 | Chromsome breakage (HP:0040012) | 2.84774684 |
| 41 | Abnormality of the pleura (HP:0002103) | 2.80755545 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.73887931 |
| 43 | Leukocytosis (HP:0001974) | 2.73583671 |
| 44 | Eosinophilia (HP:0001880) | 2.69900775 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.68980943 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.68072894 |
| 47 | Abnormality of the prostate (HP:0008775) | 2.67354011 |
| 48 | Chronic diarrhea (HP:0002028) | 2.67266541 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 2.65734291 |
| 50 | Osteomyelitis (HP:0002754) | 2.64072413 |
| 51 | Recurrent bronchitis (HP:0002837) | 2.60046199 |
| 52 | Recurrent lower respiratory tract infections (HP:0002783) | 2.59907124 |
| 53 | T lymphocytopenia (HP:0005403) | 2.59699669 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.59303843 |
| 55 | Anorexia (HP:0002039) | 2.57542590 |
| 56 | Cheilitis (HP:0100825) | 2.52948721 |
| 57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.51155672 |
| 58 | Restrictive lung disease (HP:0002091) | 2.49899460 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.48786753 |
| 60 | Colitis (HP:0002583) | 2.48781890 |
| 61 | Abnormality of eosinophils (HP:0001879) | 2.46999924 |
| 62 | Bronchitis (HP:0012387) | 2.46329466 |
| 63 | IgA deficiency (HP:0002720) | 2.46318054 |
| 64 | Abnormality of T cells (HP:0002843) | 2.45875484 |
| 65 | Recurrent sinusitis (HP:0011108) | 2.45131346 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.44922814 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.44683810 |
| 68 | Lymphopenia (HP:0001888) | 2.44046943 |
| 69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.39653376 |
| 70 | Keratitis (HP:0000491) | 2.39487984 |
| 71 | Agnosia (HP:0010524) | 2.39000622 |
| 72 | Petechiae (HP:0000967) | 2.38864323 |
| 73 | Gastrointestinal stroma tumor (HP:0100723) | 2.37687644 |
| 74 | Emphysema (HP:0002097) | 2.37070983 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 2.36426842 |
| 76 | Granulocytopenia (HP:0001913) | 2.36347545 |
| 77 | Increased cerebral lipofuscin (HP:0011813) | 2.34218621 |
| 78 | Albinism (HP:0001022) | 2.33992215 |
| 79 | Pulmonary embolism (HP:0002204) | 2.32882782 |
| 80 | Skin rash (HP:0000988) | 2.31706956 |
| 81 | Leukopenia (HP:0001882) | 2.29042058 |
| 82 | Hemoptysis (HP:0002105) | 2.28154565 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.27807526 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.27078923 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.27078923 |
| 86 | Abnormality of glycolipid metabolism (HP:0010969) | 2.27078923 |
| 87 | Encephalitis (HP:0002383) | 2.24740677 |
| 88 | IgG deficiency (HP:0004315) | 2.24350015 |
| 89 | Thrombocytosis (HP:0001894) | 2.24127907 |
| 90 | Gingival bleeding (HP:0000225) | 2.22246933 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.18956730 |
| 92 | Verrucae (HP:0200043) | 2.18837994 |
| 93 | Papilloma (HP:0012740) | 2.18837994 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 2.17317836 |
| 95 | Interstitial pulmonary disease (HP:0006530) | 2.15350131 |
| 96 | Severe combined immunodeficiency (HP:0004430) | 2.15081169 |
| 97 | Hypochromic anemia (HP:0001931) | 2.14774268 |
| 98 | Thick nail (HP:0001805) | 2.12655454 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 2.11433618 |
| 100 | Urticaria (HP:0001025) | 2.11039430 |
| 101 | Abnormality of the fingertips (HP:0001211) | 2.10845133 |
| 102 | Lymphoma (HP:0002665) | 2.10683096 |
| 103 | Sepsis (HP:0100806) | 2.10533089 |
| 104 | Clubbing of toes (HP:0100760) | 2.10458211 |
| 105 | Premature loss of primary teeth (HP:0006323) | 2.06495987 |
| 106 | Joint swelling (HP:0001386) | 2.06081311 |
| 107 | Abnormality of B cell number (HP:0010975) | 2.05819891 |
| 108 | B lymphocytopenia (HP:0010976) | 2.05819891 |
| 109 | Combined immunodeficiency (HP:0005387) | 2.05737567 |
| 110 | Arthralgia (HP:0002829) | 2.05677860 |
| 111 | Spontaneous hematomas (HP:0007420) | 2.05251598 |
| 112 | Arterial thrombosis (HP:0004420) | 2.00827129 |
| 113 | Keratoconjunctivitis (HP:0001096) | 2.00035904 |
| 114 | Autoimmune hemolytic anemia (HP:0001890) | 1.99862634 |
| 115 | Acute hepatic failure (HP:0006554) | 1.98240760 |
| 116 | Stomach cancer (HP:0012126) | 1.98007085 |
| 117 | Skin ulcer (HP:0200042) | 1.97967001 |
| 118 | Increased IgE level (HP:0003212) | 1.97921728 |
| 119 | Disinhibition (HP:0000734) | 1.96907348 |
| 120 | Polyneuropathy (HP:0001271) | 1.96808671 |
| 121 | Chronic sinusitis (HP:0011109) | 1.95180713 |
| 122 | Viral hepatitis (HP:0006562) | 1.95056412 |
| 123 | Neutropenia (HP:0001875) | 1.91251603 |
| 124 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.90537543 |
| 125 | Abnormality of the pericardium (HP:0001697) | 1.90226445 |
| 126 | Hypochromic microcytic anemia (HP:0004840) | 1.89814652 |
| 127 | Glomerulopathy (HP:0100820) | 1.88856598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.95717051 |
| 2 | MAP4K1 | 3.50368372 |
| 3 | TXK | 3.29055556 |
| 4 | IRAK4 | 3.26143811 |
| 5 | BLK | 3.25664942 |
| 6 | RIPK4 | 3.23482247 |
| 7 | IRAK3 | 2.63998371 |
| 8 | TYK2 | 2.58228747 |
| 9 | JAK3 | 2.27875724 |
| 10 | IKBKB | 2.26916261 |
| 11 | TBK1 | 2.23850071 |
| 12 | KIT | 2.21149459 |
| 13 | IKBKE | 2.19744576 |
| 14 | MAP3K13 | 2.03940222 |
| 15 | JAK1 | 2.00261361 |
| 16 | TEC | 1.89014553 |
| 17 | BTK | 1.81484145 |
| 18 | SYK | 1.73406878 |
| 19 | MST4 | 1.69968419 |
| 20 | CSF1R | 1.68847316 |
| 21 | GRK7 | 1.65652295 |
| 22 | CSK | 1.61556454 |
| 23 | TGFBR2 | 1.61016851 |
| 24 | PBK | 1.58414449 |
| 25 | FES | 1.55940198 |
| 26 | SIK2 | 1.51235389 |
| 27 | HCK | 1.50928845 |
| 28 | LYN | 1.49834263 |
| 29 | ITK | 1.49119700 |
| 30 | LCK | 1.42156019 |
| 31 | STK10 | 1.39304138 |
| 32 | EIF2AK2 | 1.38325408 |
| 33 | FGR | 1.31295791 |
| 34 | CHUK | 1.29556449 |
| 35 | CLK1 | 1.27965632 |
| 36 | ZAP70 | 1.27524747 |
| 37 | YES1 | 1.23957311 |
| 38 | TAOK3 | 1.22927863 |
| 39 | PIM1 | 1.22743957 |
| 40 | ADRBK2 | 1.16665460 |
| 41 | SIK3 | 1.16235206 |
| 42 | MATK | 1.14952970 |
| 43 | GRK6 | 1.12974950 |
| 44 | MAP3K11 | 1.12424064 |
| 45 | CDK12 | 1.12309124 |
| 46 | STK4 | 1.10646131 |
| 47 | FGFR4 | 1.07186126 |
| 48 | PRPF4B | 0.96920148 |
| 49 | MARK3 | 0.91947406 |
| 50 | BMPR2 | 0.83881880 |
| 51 | CAMKK2 | 0.83257055 |
| 52 | STK16 | 0.82968085 |
| 53 | CAMK1D | 0.81153894 |
| 54 | TRPM7 | 0.81030418 |
| 55 | NUAK1 | 0.80583149 |
| 56 | PRKCQ | 0.78737001 |
| 57 | BRD4 | 0.77864553 |
| 58 | EPHA3 | 0.75416073 |
| 59 | IRAK1 | 0.74200374 |
| 60 | GRK1 | 0.73417750 |
| 61 | NME2 | 0.71863867 |
| 62 | TLK1 | 0.69961668 |
| 63 | CAMK1G | 0.69487583 |
| 64 | FGFR3 | 0.68563612 |
| 65 | PIM2 | 0.68253591 |
| 66 | EPHB1 | 0.68213890 |
| 67 | MAPK15 | 0.68110841 |
| 68 | PKN1 | 0.67922436 |
| 69 | JAK2 | 0.67721573 |
| 70 | BMPR1B | 0.66241471 |
| 71 | CDK19 | 0.62042965 |
| 72 | RPS6KA4 | 0.61830144 |
| 73 | MAP3K5 | 0.58962151 |
| 74 | TESK2 | 0.57489696 |
| 75 | MKNK2 | 0.57416465 |
| 76 | ATR | 0.56069886 |
| 77 | MAPK11 | 0.55726814 |
| 78 | PRKCD | 0.55701437 |
| 79 | VRK1 | 0.55405860 |
| 80 | BCR | 0.54126488 |
| 81 | TAOK2 | 0.53388168 |
| 82 | ABL1 | 0.53356503 |
| 83 | PIK3CG | 0.52981674 |
| 84 | TNK2 | 0.52862261 |
| 85 | MAP3K1 | 0.52513054 |
| 86 | MOS | 0.51748018 |
| 87 | IRAK2 | 0.49573744 |
| 88 | FRK | 0.49247588 |
| 89 | TAOK1 | 0.46742989 |
| 90 | ACVR1B | 0.46000428 |
| 91 | MAP3K3 | 0.44334170 |
| 92 | TNIK | 0.44213381 |
| 93 | ZAK | 0.44175897 |
| 94 | PTK2B | 0.42490018 |
| 95 | EGFR | 0.42340604 |
| 96 | CDK6 | 0.42005578 |
| 97 | PDK1 | 0.40970511 |
| 98 | MAPKAPK2 | 0.39656925 |
| 99 | MKNK1 | 0.38518310 |
| 100 | RPS6KA5 | 0.38430134 |
| 101 | HIPK2 | 0.38317128 |
| 102 | MAP2K6 | 0.37915971 |
| 103 | KSR1 | 0.37368905 |
| 104 | ALK | 0.35933109 |
| 105 | NLK | 0.33650560 |
| 106 | CDK9 | 0.29956064 |
| 107 | KSR2 | 0.29671052 |
| 108 | FYN | 0.28660681 |
| 109 | TRIM28 | 0.28390393 |
| 110 | ERN1 | 0.27980855 |
| 111 | DYRK3 | 0.27851498 |
| 112 | CDC42BPA | 0.26158844 |
| 113 | INSR | 0.25929820 |
| 114 | MAPK7 | 0.25648981 |
| 115 | SGK2 | 0.25554336 |
| 116 | CDK4 | 0.25415375 |
| 117 | CDK7 | 0.24399340 |
| 118 | CCNB1 | 0.24156543 |
| 119 | PASK | 0.23272935 |
| 120 | MAP2K3 | 0.22400247 |
| 121 | MAP3K10 | 0.21524143 |
| 122 | MARK2 | 0.21492269 |
| 123 | EIF2AK3 | 0.21045120 |
| 124 | IGF1R | 0.21030804 |
| 125 | NEK9 | 0.20693100 |
| 126 | MAPK4 | 0.19777226 |
| 127 | SGK3 | 0.19612692 |
| 128 | CDC7 | 0.19586984 |
| 129 | SRPK1 | 0.19578492 |
| 130 | MST1R | 0.19415993 |
| 131 | PRKCZ | 0.19303552 |
| 132 | ATM | 0.18693415 |
| 133 | STK3 | 0.17385545 |
| 134 | LRRK2 | 0.16186712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75379522 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.74082131 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.68983908 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.56383139 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.53253185 |
| 6 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.46273745 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39931107 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35241680 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.27346691 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.26909265 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.24163644 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.22770276 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.18094326 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14126478 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05101651 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80303263 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.79457437 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75854384 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.74268468 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.72920484 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.72813054 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69680333 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.67849639 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.63968964 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62002671 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60559766 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59535038 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48501359 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47230310 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.46495689 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45150474 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44667630 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38343558 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36594830 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35204675 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34762734 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26608322 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26033505 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25913236 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.20837504 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.16069436 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12244257 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.12139767 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05518198 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 1.05104342 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02706849 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.02114236 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 0.99616109 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97649690 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.94992096 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.92367145 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88867557 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.87371667 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87231046 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87090875 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.85298814 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79122405 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76730920 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70334621 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67864447 |
| 61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67795623 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65589757 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 0.64891885 |
| 64 | Mismatch repair_Homo sapiens_hsa03430 | 0.63578160 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63398401 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 0.63342672 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.61204485 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59376743 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54253339 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53947081 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53859991 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53010265 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49727758 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48175217 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47429433 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46660691 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45502659 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45316570 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44228884 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39837014 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39809985 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38662815 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38128384 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38016599 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36469521 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35788558 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33413998 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32887599 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30215769 |
| 90 | Proteasome_Homo sapiens_hsa03050 | 0.29711535 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.29591800 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.29542837 |
| 93 | Spliceosome_Homo sapiens_hsa03040 | 0.29260670 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28626452 |
| 95 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.27943155 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.27475470 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27072299 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26953003 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25615185 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.25505913 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25323549 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23745987 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23674611 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22992462 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22906675 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22051099 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19436871 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16080778 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10286577 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.09178465 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08884148 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06033174 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05737571 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.03676627 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.01113717 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.00680222 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | -0.0286051 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0168941 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0091696 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0014719 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | -0.0011070 |

